Skip to main content

Blog

Fiscal Year 2024 Appropriations Package Signed Into Law, Including Critical Funding for Duchenne and Becker

...

ITF Therapeutics Shares Update on DUVYZAT™ Following FDA Approval

...

FDA Grants Approval to DUVYZAT™ (Givinostat)

...

Italfarmaco Shares Updates Ahead of Givinostat PDUFA Date

...

PPMD’s 2024 Advocacy Conference Brings Together Community to Support Progress in Fighting for Every Future

...

WATCH: Sarepta Therapeutics – Data update from MOMENTUM study, SRP-5051 (Webinar Recording)

...

PTC Therapeutics Announces Plans to Resubmit Translarna™ NDA to FDA

...

WATCH: NS Pharma – Overview of New Exon Skipping Trials: Brogidirsen and NS-050/NCNP-03 (Webinar Recording)

...

The Duchenne Registry Has a New Gene Therapy Survey!

...

Join Us in Orlando for PPMD’s 30th Annual Conference

...